Forma Therapeutics Announces FT-4202 Receives Orphan Drug Designation In Europe For Treatment Of Sickle Cell Disease Read more
ImmunityBio, NantKwest Announce Positive Interim Phase 1 Safety Data of hAd5 COVID-19 Vaccine Dose Study Read more
ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women Read more
Ultragenyx Announces Plans to Build Large-scale Gene Therapy Manufacturing Facility to Support Pipeline of Therapies for Rare Diseases Read more